Klopman Gilles, Stefan Liliana R, Saiakhov Roustem D
Department of Chemistry, Case Western Reserve University, 2074 Adelbert Road R205N, Cleveland, OH 44106, USA.
Eur J Pharm Sci. 2002 Dec;17(4-5):253-63. doi: 10.1016/s0928-0987(02)00219-1.
To develop a computational method to rapidly evaluate human intestinal absorption, one of the drug properties included in the term ADME (Absorption, Distribution, Metabolism, Excretion). Poor ADME properties are the most important reason for drug failure in clinical development.
The model developed is based on a modified contribution group method in which the basic parameters are structural descriptors identified by the CASE program, together with the number of hydrogen bond donors.
The human intestinal absorption model is a quantitative structure-activity relationship (QSAR) that includes 37 structural descriptors derived from the chemical structures of a data set containing 417 drugs. The model was able to predict the percentage of drug absorbed from the gastrointestinal tract with an r2 of 0.79 and a standard deviation of 12.32% of the compounds from the training set. The standard deviation for an external test set (50 drugs) was 12.34%.
The availability of reliable and fast models like the one we propose here to predict ADME/Tox properties could help speed up the process of finding compounds with improved properties, ultimately making the entire drug discovery process shorter and more cost efficient.
开发一种计算方法,以快速评估人体肠道吸收情况,这是ADME(吸收、分布、代谢、排泄)一词所包含的药物性质之一。ADME性质不佳是临床开发中药物失败的最重要原因。
所开发的模型基于一种改进的贡献基团法,其中基本参数是由CASE程序识别的结构描述符,以及氢键供体的数量。
人体肠道吸收模型是一种定量构效关系(QSAR),包含37个从包含417种药物的数据集的化学结构中得出的结构描述符。该模型能够预测从胃肠道吸收的药物百分比,训练集中化合物的r2为0.79,标准差为12.32%。外部测试集(50种药物)的标准差为12.34%。
像我们在此提出的这种可靠且快速的模型可用于预测ADME/毒性性质,这有助于加快寻找具有改进性质的化合物的过程,最终使整个药物发现过程更短且更具成本效益。